It's all a matter of necessity and concern: A structural equation model of adherence to antihypertensive medication

Marcel Wilhelm1, Winfried Rief1, Bettina K Doering1

  • 1Department of Clinical Psychology and Psychotherapy, Philipps University of Marburg, Marburg, Germany.

Insights

Poor adherence to hypertension medication is common. The necessity-concern framework (NCF) mediates adherence by influencing beliefs about medication, with personalized communication improving outcomes.

Area of Science:

  • Cardiology
  • Psychology
  • Health Services Research

Background:

  • Hypertension pharmacotherapy adherence is suboptimal.
  • Patient beliefs about medication, specifically the necessity-concern framework (NCF), are crucial for adherence.
  • Previous models explaining adherence in hypercholesterolemia were adapted for hypertension.

Purpose of the Study:

  • To validate a structural equation model (SEM) for hypertension medication adherence.
  • To investigate the mediating role of the necessity-concern framework (NCF) in hypertension treatment.
  • To identify factors influencing necessity and concern beliefs about antihypertensive medication.

Main Methods:

  • Online survey of 273 hypertension patients.
  • Collected data on demographics, health factors, and medication beliefs (necessity, concern).
  • Structural equation modeling (SEM) was used for data analysis.

Main Results:

  • Necessity beliefs positively correlated with adherence (β=0.26, p=0.009).
  • Concern beliefs negatively correlated with adherence (β=-0.51, p=0.020).
  • The NCF model explained 23% of adherence variance, outperforming previous models.

Conclusions:

  • The necessity-concern framework (NCF) effectively mediates adherence in hypertension.
  • Factors like comorbidity, treatment duration, doctor-patient communication, side effects, and control beliefs influence NCF components.
  • Personalized, supportive doctor-patient communication may enhance medication adherence.
Abstract

Related Concept Videos

Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.6K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.6K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
752
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.1K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.8K